Phase 2 Graves Disease Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves Disease
Immunovant Sciences GmbH210 enrolled145 locationsNCT07018323
Recruiting
Phase 2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves Disease
Immunovant Sciences GmbH240 enrolled134 locationsNCT06727604
Recruiting
Phase 2
A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease
Graves Disease
Sanofi30 enrolled13 locationsNCT06984627
Recruiting
Phase 2
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
Graves DiseaseHyperthyroidism
Northwell Health30 enrolled1 locationNCT07369063
Recruiting
Phase 2Phase 3
Graves' Disease Remission Study: MycoMeth Combo
Graves Disease
The First Affiliated Hospital of Xiamen University205 enrolled1 locationNCT06068179